跳至主要内容
临床试验/ITMCTR2100004233
ITMCTR2100004233尚未招募1 期

A prospective cohort study of Chinese medicine intervention in overweight/obese patients with abnormal glucose tolerance (IGT)

The Affiliated Hospital of Changchun University of Chinese Medicine0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
1 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
18 至 75(—)
性别
All

入选标准

  • 1) Aged 18 to 75 years;
  • 2) Meet the diagnostic criteria of Western medicine for IGT;
  • 3) Meet the diagnostic criteria of western medicine for overweight/obese or central obesity;
  • 4) Informed consent has been signed.

排除标准

  • 1) Patients who have been diagnosed with type 1 diabetes, type 2 diabetes, gestational diabetes, secondary diabetes and other special types of diabetes;
  • 2) People who have used hypoglycemic drugs continuously in recent 3 months;
  • 3) Patients with severe other diseases or mental disorders;
  • 4) Allergic to the known ingredients of the study drug and allergic constitution;
  • 5) Pregnant or lactating women and those who have recently had family planning;
  • 6) Patients with impaired liver and kidney function (ALT and AST are twice higher than the upper limit of normal value, and serum creatinine is abnormal).

研究者

发起方
The Affiliated Hospital of Changchun University of Chinese Medicine

相似试验

A prospective cohort study of Chinese medicine... | 临床试验